These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1166858)

  • 41. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients.
    Saisoong S; Eiam-Ong S; Hanvivatvong O
    Clin Exp Rheumatol; 2006; 24(1):51-8. PubMed ID: 16539819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)].
    Hashimoto H; Utagawa Y; Yamagata J; Okada T; Shiokawa Y; Suzuki S; Tomiyama T
    Ryumachi; 1981 Sep; 21(5):366-74. PubMed ID: 6977194
    [No Abstract]   [Full Text] [Related]  

  • 43. [Determination of anti-native DNA antibodies by immunofluorescence on Crithidia luciliae. Correlation between renal involvement and the presence of high-avidity anti-native DNA antibodies in lupic disease].
    Meyer O; Borda-Iriarte O; Haïm T; Ryckewaert A
    Presse Med; 1984 Dec; 13(46):2801-5. PubMed ID: 6240645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features.
    Gladman DD; Urowitz MB; Keystone EC
    Am J Med; 1979 Feb; 66(2):210-5. PubMed ID: 218447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Circulating interferon in patients with systemic lupus erythematosus. A prospective study].
    Dudli C; Kaiser V; Aguet M; Joller H; Pichler WI; Grob PJ; Fontana A
    Schweiz Med Wochenschr; 1986 Jan; 116(4):104-9. PubMed ID: 2419975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnostic and prognostic significance of complement fixing anti-n-DNA antibodies in systemic lupus erythematosus].
    Pozzoli R
    Quad Sclavo Diagn; 1987 Mar; 23(1):65-71. PubMed ID: 3441594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic lupus with nephritis: a long-term study.
    Cameron JS; Turner DR; Ogg CS; Williams DG; Lessof MH; Chantler C; Leibowitz S
    Q J Med; 1979 Jan; 48(189):1-24. PubMed ID: 482585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of circulating immune complex size in systemic lupus erythematosus.
    Tung KS; DeHoratius RJ; Williams RC
    Clin Exp Immunol; 1981 Mar; 43(3):615-25. PubMed ID: 7285395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
    Verma J; Arora V; Marwaha V; Kumar A; Das N
    Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody avidity for native DNA in lupus nephritis.
    Koyama A; Narita M; Tojo S
    Contrib Nephrol; 1975; 4():72-82. PubMed ID: 1235100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody.
    Tron F; Letarte J; Roque-Antunes Barreira MC; Lesavre P
    Clin Exp Immunol; 1982 Aug; 49(2):481-7. PubMed ID: 6982138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunological tests in the diagnosis and prognosis of disseminated lupus erythematosus, before treatment (author's transl)].
    Tron F; Bach JF
    Nouv Presse Med; 1977 Sep; 6(29):2573-8. PubMed ID: 302934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-RNA polymerase III antibody in lupus patients with proteinuria.
    Liao HT; Tung HY; Tsai CY
    J Chin Med Assoc; 2019 Apr; 82(4):260-264. PubMed ID: 30946206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus.
    Abdou NI; Wall H; Lindsley HB; Halsey JF; Suzuki T
    J Clin Invest; 1981 May; 67(5):1297-304. PubMed ID: 6971876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Necrotizing glomerulitis of systemic lupus erythematosus.
    Schwartz MM; Roberts JL; Lewis EJ
    Hum Pathol; 1983 Feb; 14(2):158-67. PubMed ID: 6187657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new specific assay for the detection of DNA immune complexes: its relevance in SLE.
    Klemp P; Meyers OL; Harley EH
    Ann Rheum Dis; 1983 Jun; 42(3):317-22. PubMed ID: 6859963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nephritis in children and young adults with systemic lupus erythematosus and normal urinary sediment.
    Woolf A; Croker B; Osofsky SG; Kredich DW
    Pediatrics; 1979 Nov; 64(5):678-85. PubMed ID: 386241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunological studies of the placenta in systemic lupus erythematosus.
    Grennan DM; McCormick JN; Wojtacha D; Carty M; Behan W
    Ann Rheum Dis; 1978 Apr; 37(2):129-34. PubMed ID: 348129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
    Smykał-Jankowiak K; Niemir ZI; Polcyn-Adamczak M
    Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasmapheresis in the management of acute systemic lupus erythematosus?
    Jones JV; Cumming RH; Bucknall RC; Asplin CM
    Lancet; 1976 Apr; 1(7962):709-11. PubMed ID: 56531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.